Moltic Pharma

Moltic Pharma is a drug discovery company developing ion channel modulators for neurological diseases, focusing on epilepsy. Our modulators are small molecule compounds that open a voltage-gated potassium channel, the Kv7.2/7.3 channel, via a unique binding site and mechanism of action. To open this ion channel is a clinically validated strategy to prevent epileptic seizures.


Visit site